Provided by Tiger Trade Technology Pte. Ltd.

Lantern Pharma Inc.

2.34
+0.05002.18%
Post-market: 2.380.0400+1.71%19:30 EDT
Volume:185.08K
Turnover:427.98K
Market Cap:29.86M
PE:-1.43
High:2.41
Open:2.32
Low:2.13
Close:2.29
52wk High:4.70
52wk Low:1.11
Shares:12.76M
Float Shares:10.14M
Volume Ratio:1.23
T/O Rate:1.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6362
EPS(LYR):-1.5709
ROE:-400.92%
ROA:-74.29%
PB:-9.28
PE(LYR):-1.49

Loading ...

Jan 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 11, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 08, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jan 06, 2021

Major Issues Report

8-K - Current report
Oct 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2020

Major Issues Report

8-K - Current report
Aug 21, 2020

Major Issues Report

8-K - Current report
Jul 30, 2020

Major Issues Report

8-K - Current report
Jul 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 16, 2020

Major Issues Report

8-K - Current report
Jun 23, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 23, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 19, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 17, 2020

Major Issues Report

8-K - Current report
Jun 08, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 08, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 08, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 02, 2020

Correspondence

CORRESP [Cover] - Correspondence